\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\\.\ \(14\)\
\-\ surgical\\ resection\\ with\\ continued\\ follow\\ up\\ to\\ monitor\\ for\\ residual\\ or\\ recurrent\\ tumor\\.\ \(0\)\
\-\ there\\ is\\ a\\ smoothly\\ marginated\\,\\ extra\\-axial\\ mass\\ which\\ is\\ located\\ along\\ the\\ root\\ entry\\ zone\\ of\\ the\\ trigeminal\\ nerve\\ and\\ within\\ meckel\\â\\€\\™s\\ cave\\ on\\ the\\ right\\.\\ \\ the\\ mass\\ measures\\ approximately\\ 1\\.4\\ cm\\ ap\\ x\\ 1\\.1\\ cm\\ transverse\\ x\\ 1\\.5\\ cm\\ craniocaudal\\.\\ \\ the\\ mass\\ is\\ isointense\\ to\\ brain\\ on\\ the\\ t1\\ and\\ t2\\ weighted\\ sequences\\.\\ \\ it\\ has\\ diffuse\\ homogenous\\ enhancement\\ on\\ the\\ post\\ gadolinium\\ images\\.\\ \\ the\\ mass\\ extends\\ to\\ foramen\\ ovale\\ on\\ the\\ right\\;\\ but\\ does\\ not\\ pass\\ through\\.\\ \\ there\\ is\\ minimal\\ mass\\ effect\\ on\\ the\\ adjacent\\ right\\ temporal\\ lobe\\.\\ \\ \\ \\ there\\ is\\ atrophy\\ and\\ fatty\\ infiltration\\ of\\ the\\ muscles\\ of\\ mastication\\,\\ ipsilateral\\ to\\ the\\ mass\\ lesion\\.\ \(0\)\
\-\ trigeminal\\ schwannoma\ \(7\)\
\-\ meningioma\ \(167\)\
\-\ schwannoma\ \(67\)\
\-\ epidermoid\ \(89\)\
\-\ dermoid\ \(313\)\
\-\ lymphoma\ \(373\)\
\-\ sarcoid\ \(163\)\
\-\ primary\\ melanoma\ \(3\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ vascular\\ lesions\\ \\(aneurysm\\,\\ carotid\\-cavernous\\ fistula\\)\ \(0\)\
\-\ paraganglioma\ \(36\)\
\-\ the\\ patient\\ presented\\ with\\ right\\ sided\\ facial\\ pain\\ and\\ headaches\\.\ \(0\)\
\-\ the\\ patient\\ in\\ this\\ case\\ presented\\ with\\ facial\\ pain\\ and\\ headaches\\.\\ \\ the\\ main\\ symptoms\\ of\\ trigeminal\\ schwannomas\\ are\\ facial\\ numbness\\,\\ hyperesthesia\\,\\ and\\ pain\\.\\ \\ memory\\ loss\\ and\\ seizures\\ can\\ also\\ occur\\.\\ \\ the\\ trigeminal\\ schwannoma\\ in\\ this\\ case\\ involved\\ the\\ cerebellopontine\\ angle\\ at\\ the\\ root\\ entry\\ zone\\ of\\ the\\ trigeminal\\ nerve\\ along\\ the\\ pons\\.\\ \\ the\\ tumor\\ also\\ involved\\ meckel\\â\\€\\™s\\ cave\\.\\ \\ it\\ did\\ not\\ extend\\ through\\ the\\ foramen\\ of\\ ovale\\.\\ \\ four\\ distinct\\ types\\ of\\ trigeminal\\ schwannomas\\ have\\ been\\ categorized\\.\\ \\ the\\ four\\ categories\\ include\\ those\\ confined\\ to\\ the\\ cavernous\\ sinus\\,\\ those\\ located\\ within\\ meckel\\â\\€\\™s\\ cave\\,\\ those\\ located\\ within\\ the\\ cerebellopontine\\ angle\\,\\ and\\ those\\ that\\ involve\\ both\\ the\\ posterior\\ and\\ middle\\ cranial\\ fossa\\.\\ \\ the\\ tumor\\ in\\ this\\ case\\ fits\\ into\\ the\\ last\\ category\\ where\\ it\\ is\\ a\\ giant\\ trigeminal\\ schwannoma\\ involving\\ both\\ the\\ posterior\\ and\\ middle\\ cranial\\ fossa\\.\\ \\ \ \(0\)\
\-\ trigeminal\\ schwannomas\\ are\\ uncommon\\ tumors\\ that\\ account\\ for\\ 0\\.07\\-0\\.36\\%\\ of\\ all\\ intracranial\\ tumors\\.\\ \\ the\\ peak\\ incidence\\ of\\ trigeminal\\ schwannomas\\ occurs\\ in\\ the\\ fourth\\ decade\\ of\\ life\\ which\\ is\\ consistent\\ with\\ the\\ age\\ at\\ presentation\\ for\\ the\\ patient\\ in\\ this\\ case\\.\\ \\ this\\ tumor\\â\\€\\™s\\ mri\\ signal\\ characteristics\\ were\\ very\\ typical\\ for\\ schwannomas\\.\\ schwannomas\\ are\\ typically\\ isointense\\ to\\ hypointense\\ on\\ t1\\ weighted\\ images\\,\\ hyperintense\\ on\\ t2\\ weighted\\ images\\,\\ well\\ circumscribed\\,\\ and\\ show\\ strong\\ enhancement\\.\\ \\ although\\ this\\ tumor\\ did\\ not\\ have\\ any\\ cystic\\ components\\,\\ trigeminal\\ schwannomas\\ are\\ more\\ likely\\ to\\ contain\\ cystic\\ areas\\ than\\ vestibular\\ \\(\\"acoustic\\"\\)\\ schwannomas\\.\\ \\ \\ pertinent\\ anatomy\\ for\\ the\\ trigeminal\\ nerve\\ is\\ as\\ follows\\:\ \(0\)\
\-\ the\\ trigeminal\\ nerve\\ exits\\ the\\ brainstem\\ at\\ the\\ mid\\-pons\\,\\ passes\\ through\\ the\\ cerebellopontine\\ angle\\,\\ and\\ enters\\ meckel\\â\\€\\™s\\ cave\\ where\\ the\\ trigeminal\\ ganglion\\ \\(gasserian\\ ganglion\\)\\ is\\ located\\.\\ \\ the\\ nerve\\ then\\ branches\\ into\\ three\\ segments\\.\\ \\ the\\ mandibular\\ nerve\\ \\(v3\\)\\ passes\\ anteriorly\\ through\\ meckel\\â\\€\\™s\\ cave\\ and\\ exits\\ inferiorly\\ through\\ the\\ foramen\\ of\\ ovale\\ into\\ the\\ infratemporal\\ fossa\\.\\ \\ the\\ maxillary\\ nerve\\ \\(v2\\)\\ enters\\ the\\ lateral\\ wall\\ of\\ the\\ cavernous\\ sinus\\ with\\ the\\ ophthalmic\\ nerve\\ \\(v1\\)\\.\\ \\ the\\ maxillary\\ nerve\\ then\\ exits\\ the\\ middle\\ cranial\\ fossa\\ through\\ the\\ foramen\\ rotundum\\ and\\ the\\ ophthalmic\\ nerve\\ exits\\ through\\ the\\ superior\\ orbital\\ fissure\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ trigeminal\\:\\ 0\\.46365463174353005\ \(0\)\
\-\ the\\:\\ 0\\.334059852191598\ \(0\)\
\-\ schwannomas\\:\\ 0\\.3152753286765202\ \(0\)\
\-\ nerve\\:\\ 0\\.22968314224826447\ \(0\)\
\-\ cave\\:\\ 0\\.2183187628435986\ \(0\)\
\-\ meckel\\:\\ 0\\.17587321550470658\ \(0\)\
\-\ exits\\:\\ 0\\.17199591019059507\ \(0\)\
\-\ through\\:\\ 0\\.1341577325559112\ \(0\)\
\-\ ovale\\:\\ 0\\.12277054578441904\ \(0\)\
\-\ foramen\\:\\ 0\\.11447820973472912\ \(0\)\
\-\ schwannoma\\:\\ 0\\.11036207141025994\ \(0\)\
\-\ those\\:\\ 0\\.11019906523634147\ \(0\)\
\-\ cerebellopontine\\:\\ 0\\.1080558294456762\ \(0\)\
\-\ located\\:\\ 0\\.10187224235346234\ \(0\)\
\-\ fossa\\:\\ 0\\.1010993854722324\ \(0\)\
\-\ and\\:\\ 0\\.09314013930471104\ \(0\)\
\-\ enters\\:\\ 0\\.08480863205524934\ \(0\)\
\-\ angle\\:\\ 0\\.08471992963000473\ \(0\)\
\-\ tumor\\:\\ 0\\.08420134673132582\ \(0\)\
\-\ cavernous\\:\\ 0\\.08378273115095036\ \(0\)\
\-\ entry\\:\\ 0\\.08275056289301476\ \(0\)\
\-\ facial\\:\\ 0\\.07964360011357245\ \(0\)\
\-\ is\\:\\ 0\\.07935333751378411\ \(0\)\
\-\ cranial\\:\\ 0\\.07894423610640028\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.07643354796564064\ \(0\)\
\-\ of\\:\\ 0\\.07560689750599543\ \(0\)\
\-\ passes\\:\\ 0\\.07492622844630731\ \(0\)\
\-\ mass\\:\\ 0\\.07378760782563125\ \(0\)\
\-\ ganglion\\:\\ 0\\.0724073553641172\ \(0\)\
\-\ weighted\\:\\ 0\\.07204622948088918\ \(0\)\
\-\ middle\\:\\ 0\\.0690680148122075\ \(0\)\
\-\ on\\:\\ 0\\.06806578138765777\ \(0\)\
\-\ this\\:\\ 0\\.06637833204071865\ \(0\)\
\-\ pons\\:\\ 0\\.06619836162953112\ \(0\)\
\-\ case\\:\\ 0\\.06469927145106917\ \(0\)\
\-\ maxillary\\:\\ 0\\.06385450179731707\ \(0\)\
\-\ zone\\:\\ 0\\.06221566861364767\ \(0\)\
\-\ root\\:\\ 0\\.06092006785575575\ \(0\)\
\-\ isointense\\:\\ 0\\.058266005990035626\ \(0\)\
\-\ to\\:\\ 0\\.05634220048634202\ \(0\)\
\-\ cm\\:\\ 0\\.055471232766277905\ \(0\)\
\-\ four\\:\\ 0\\.05218174422627762\ \(0\)\
\-\ involved\\:\\ 0\\.051630994583376374\ \(0\)\
\-\ gasserian\\:\\ 0\\.05148808701542717\ \(0\)\
\-\ into\\:\\ 0\\.05134419288777746\ \(0\)\
\-\ not\\:\\ 0\\.05084053777664682\ \(0\)\
\-\ where\\:\\ 0\\.0506040934607053\ \(0\)\
\-\ it\\:\\ 0\\.049441734088467186\ \(0\)\
\-\ mastication\\:\\ 0\\.04919961589321484\ \(0\)\
\-\ are\\:\\ 0\\.04886736146138466\ \(0\)\
\-\ for\\:\\ 0\\.04879149353338542\ \(0\)\
\-\ headaches\\:\\ 0\\.04803081965392612\ \(0\)\
\-\ hyperesthesia\\:\\ 0\\.04757591979207344\ \(0\)\
\-\ tumors\\:\\ 0\\.04735670125842252\ \(0\)\
\-\ sinus\\:\\ 0\\.04652892842443267\ \(0\)\
\-\ rotundum\\:\\ 0\\.046316483250978396\ \(0\)\
\-\ did\\:\\ 0\\.046191944340158324\ \(0\)\
\-\ then\\:\\ 0\\.045581626598577056\ \(0\)\
\-\ images\\:\\ 0\\.04467809755291242\ \(0\)\
\-\ within\\:\\ 0\\.04448517264666732\ \(0\)\
\-\ v3\\:\\ 0\\.044417412328386384\ \(0\)\
\-\ infratemporal\\:\\ 0\\.044417412328386384\ \(0\)\
\-\ along\\:\\ 0\\.043139901634979924\ \(0\)\
\-\ v2\\:\\ 0\\.04299897754764877\ \(0\)\
\-\ right\\:\\ 0\\.042696954145855275\ \(0\)\
\-\ fits\\:\\ 0\\.04137528144650738\ \(0\)\
\-\ v1\\:\\ 0\\.04137528144650738\ \(0\)\
\-\ categorized\\:\\ 0\\.04092351526147301\ \(0\)\
\-\ t1\\:\\ 0\\.04011998571495288\ \(0\)\
\-\ in\\:\\ 0\\.040046345923026395\ \(0\)\
\-\ cystic\\:\\ 0\\.0387808654064433\ \(0\)\
\-\ there\\:\\ 0\\.03843182205316409\ \(0\)\
\-\ categories\\:\\ 0\\.03821677398282032\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.03770332342148478\ \(0\)\
\-\ presented\\:\\ 0\\.03754952932058677\ \(0\)\
\-\ smoothly\\:\\ 0\\.037463114223153654\ \(0\)\
\-\ memory\\:\\ 0\\.037463114223153654\ \(0\)\
\-\ enhancement\\:\\ 0\\.03706267955246319\ \(0\)\
\-\ t2\\:\\ 0\\.037046260453561776\ \(0\)\
\-\ category\\:\\ 0\\.037011348038119285\ \(0\)\
\-\ at\\:\\ 0\\.03648227932961489\ \(0\)\
\-\ both\\:\\ 0\\.03590791455363387\ \(0\)\
\-\ mandibular\\:\\ 0\\.035174643100941316\ \(0\)\
\-\ paraganglioma\\:\\ 0\\.035020001530177564\ \(0\)\
\-\ pain\\:\\ 0\\.03456252208071982\ \(0\)\
\-\ confined\\:\\ 0\\.034440614888900975\ \(0\)\
\-\ homogenous\\:\\ 0\\.0341717991201958\ \(0\)\
\-\ distinct\\:\\ 0\\.0341717991201958\ \(0\)\
\-\ marginated\\:\\ 0\\.03391520655984626\ \(0\)\
\-\ decade\\:\\ 0\\.03391520655984626\ \(0\)\
\-\ strong\\:\\ 0\\.03355094699979992\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.033320545039822166\ \(0\)\
\-\ posterior\\:\\ 0\\.03329744772623005\ \(0\)\
\-\ pass\\:\\ 0\\.033208777738998954\ \(0\)\
\-\ vestibular\\:\\ 0\\.033208777738998954\ \(0\)\
\-\ peak\\:\\ 0\\.03299167157846137\ \(0\)\
\-\ monitor\\:\\ 0\\.03288617197872898\ \(0\)\
\-\ account\\:\\ 0\\.03278260826111203\ \(0\)\
\-\ pertinent\\:\\ 0\\.0326809106583252\ \(0\)\
\-\ segments\\:\\ 0\\.0326809106583252\ \(0\)\
\-\ brainstem\\:\\ 0\\.03248285299461376\ \(0\)\
\-\ acoustic\\:\\ 0\\.032291510458704875\ \(0\)\
\-\ contain\\:\\ 0\\.032198218016447226\ \(0\)\
\-\ have\\:\\ 0\\.03216713228790282\ \(0\)\
\-\ branches\\:\\ 0\\.031927250898658534\ \(0\)\
\-\ infiltration\\:\\ 0\\.03175357367999474\ \(0\)\
\-\ with\\:\\ 0\\.031521696920516304\ \(0\)\
\-\ follows\\:\\ 0\\.03150268507591872\ \(0\)\
\-\ fissure\\:\\ 0\\.031421474117230154\ \(0\)\
\-\ patient\\:\\ 0\\.03141502862122568\ \(0\)\
\-\ inferiorly\\:\\ 0\\.030883537338520017\ \(0\)\
\-\ fatty\\:\\ 0\\.030597700856516637\ \(0\)\
\-\ anatomy\\:\\ 0\\.03052844766554725\ \(0\)\
\-\ atrophy\\:\\ 0\\.030460033927877876\ \(0\)\
\-\ also\\:\\ 0\\.03028795955623799\ \(0\)\
\-\ sarcoid\\:\\ 0\\.030194381872401425\ \(0\)\
\-\ melanoma\\:\\ 0\\.03006610216297818\ \(0\)\
\-\ types\\:\\ 0\\.029940673351078497\ \(0\)\
\-\ extend\\:\\ 0\\.0296978804657019\ \(0\)\
\-\ characteristics\\:\\ 0\\.029522403194638138\ \(0\)\
\-\ residual\\:\\ 0\\.02929661051564523\ \(0\)\
\-\ which\\:\\ 0\\.029279497643148442\ \(0\)\
\-\ components\\:\\ 0\\.029241546037397297\ \(0\)\
\-\ anteriorly\\:\\ 0\\.02918701359141183\ \(0\)\
\-\ uncommon\\:\\ 0\\.029133002995017813\ \(0\)\
\-\ fistula\\:\\ 0\\.02907950435510764\ \(0\)\
\-\ fourth\\:\\ 0\\.028870441037758304\ \(0\)\
\-\ giant\\:\\ 0\\.02871857364461357\ \(0\)\
\-\ numbness\\:\\ 0\\.02861955243368228\ \(0\)\
\-\ involve\\:\\ 0\\.02833250425904817\ \(0\)\
\-\ hypointense\\:\\ 0\\.02833250425904817\ \(0\)\
\-\ orbital\\:\\ 0\\.02823997654333491\ \(0\)\
\-\ main\\:\\ 0\\.02805935107283672\ \(0\)\
\-\ epidermoid\\:\\ 0\\.027971160774629737\ \(0\)\
\-\ that\\:\\ 0\\.02794353623327107\ \(0\)\
\-\ incidence\\:\\ 0\\.0277145682142802\ \(0\)\
\-\ muscles\\:\\ 0\\.027590517852564986\ \(0\)\
\-\ dermoid\\:\\ 0\\.027195667083470106\ \(0\)\
\-\ gadolinium\\:\\ 0\\.026826642589200474\ \(0\)\
\-\ extends\\:\\ 0\\.02651396831882769\ \(0\)\
\-\ life\\:\\ 0\\.02641347787340879\ \(0\)\
\-\ continued\\:\\ 0\\.02638037476237227\ \(0\)\
\-\ seizures\\:\\ 0\\.026282214649047692\ \(0\)\
\-\ measures\\:\\ 0\\.02624987035278138\ \(0\)\
\-\ last\\:\\ 0\\.026185732568811813\ \(0\)\
\-\ intracranial\\:\\ 0\\.025905804246305605\ \(0\)\
\-\ recurrent\\:\\ 0\\.025815497291688187\ \(0\)\
\-\ sequences\\:\\ 0\\.025756085540443792\ \(0\)\
\-\ hyperintense\\:\\ 0\\.02561023597128441\ \(0\)\
\-\ occurs\\:\\ 0\\.0253844432922915\ \(0\)\
\-\ circumscribed\\:\\ 0\\.024932677107257134\ \(0\)\
\-\ typical\\:\\ 0\\.02488182933764931\ \(0\)\
\-\ transverse\\:\\ 0\\.024806406421259843\ \(0\)\
\-\ temporal\\:\\ 0\\.024731978121797657\ \(0\)\
\-\ minimal\\:\\ 0\\.024562036467670426\ \(0\)\
\-\ aneurysm\\:\\ 0\\.02451440695081678\ \(0\)\
\-\ meningioma\\:\\ 0\\.024125006751196453\ \(0\)\
\-\ occur\\:\\ 0\\.02367835062921126\ \(0\)\
\-\ ap\\:\\ 0\\.023114447028644722\ \(0\)\
\-\ very\\:\\ 0\\.023095972170079162\ \(0\)\
\-\ typically\\:\\ 0\\.02260180109547396\ \(0\)\
\-\ effect\\:\\ 0\\.022584927946129152\ \(0\)\
\-\ involving\\:\\ 0\\.02255133222638604\ \(0\)\
\-\ does\\:\\ 0\\.02225764413813818\ \(0\)\
\-\ presentation\\:\\ 0\\.02216304866822791\ \(0\)\
\-\ although\\:\\ 0\\.021918281240659605\ \(0\)\
\-\ areas\\:\\ 0\\.021858712727270656\ \(0\)\
\-\ available\\:\\ 0\\.021843918317090066\ \(0\)\
\-\ three\\:\\ 0\\.021612334477880215\ \(0\)\
\-\ vascular\\:\\ 0\\.021255169908400186\ \(0\)\
\-\ superior\\:\\ 0\\.020931824670336517\ \(0\)\
\-\ adjacent\\:\\ 0\\.02086932055145896\ \(0\)\
\-\ any\\:\\ 0\\.020807501047866828\ \(0\)\
\-\ sided\\:\\ 0\\.020709976992947413\ \(0\)\
\-\ resection\\:\\ 0\\.020637924130329433\ \(0\)\
\-\ approximately\\:\\ 0\\.020543262552869677\ \(0\)\
\-\ show\\:\\ 0\\.020438632206835634\ \(0\)\
\-\ age\\:\\ 0\\.020212839527842724\ \(0\)\
\-\ diffuse\\:\\ 0\\.020190749228597354\ \(0\)\
\-\ brain\\:\\ 0\\.020070774263337945\ \(0\)\
\-\ primary\\:\\ 0\\.019796941325315093\ \(0\)\
\-\ loss\\:\\ 0\\.01961485894612212\ \(0\)\
\-\ wall\\:\\ 0\\.019585074896782108\ \(0\)\
\-\ likely\\:\\ 0\\.019239411940882113\ \(0\)\
\-\ lymphoma\\:\\ 0\\.019174590145899353\ \(0\)\
\-\ all\\:\\ 0\\.019165390365130174\ \(0\)\
\-\ include\\:\\ 0\\.019156205555532404\ \(0\)\
\-\ been\\:\\ 0\\.01875763546883851\ \(0\)\
\-\ lobe\\:\\ 0\\.018605768075693776\ \(0\)\
\-\ lesions\\:\\ 0\\.018490410922092634\ \(0\)\
\-\ signal\\:\\ 0\\.018250881444874183\ \(0\)\
\-\ than\\:\\ 0\\.018250881444874183\ \(0\)\
\-\ more\\:\\ 0\\.01767893563982575\ \(0\)\
\-\ metastatic\\:\\ 0\\.017657783594136233\ \(0\)\
\-\ symptoms\\:\\ 0\\.017615715839740722\ \(0\)\
\-\ post\\:\\ 0\\.01751876020458975\ \(0\)\
\-\ consistent\\:\\ 0\\.017457299732454124\ \(0\)\
\-\ follow\\:\\ 0\\.01735632987955577\ \(0\)\
\-\ can\\:\\ 0\\.0168953338245131\ \(0\)\
\-\ were\\:\\ 0\\.016596002588986983\ \(0\)\
\-\ mri\\:\\ 0\\.016526464983481908\ \(0\)\
\-\ lateral\\:\\ 0\\.015978066544219016\ \(0\)\
\-\ up\\:\\ 0\\.0159260471506159\ \(0\)\
\-\ but\\:\\ 0\\.015920871483813725\ \(0\)\
\-\ surgical\\:\\ 0\\.015648207133995153\ \(0\)\
\-\ well\\:\\ 0\\.015589363185670295\ \(0\)\
\-\ lesion\\:\\ 0\\.015435380868087564\ \(0\)\
\-\ has\\:\\ 0\\.014706101553468541\ \(0\)\
\-\ disease\\:\\ 0\\.013514651439954721\ \(0\)\
\-\ as\\:\\ 0\\.012934193935971536\ \(0\)\
\-\ or\\:\\ 0\\.01120034417395091\ \(0\)\
